DAB2IP and malignant colon neoplasm: Of note, DAB2IP was found to be upregulated by ubenimex in a high-throughput mass spectrometry survey of drug effects in colon cancer cells (DeepCoverMOA, [27]), an observation that indirectly validates our screening approach.